Lexicon Pharmaceuticals
LXRX
#7701
Rank
A$0.47 B
Marketcap
$1.31
Share price
-0.71%
Change (1 day)
-54.75%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$1.02

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.09. In 2022 the company made an earnings per share (EPS) of -$0.98 an increase over its 2021 EPS that were of -$0.98.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.024.32%
2022-$0.98-0%
2021-$0.9810.91%
2020-$0.88-145.08%
2019$1.96-206.09%
2018-$1.84-5.74%
2017-$1.96-10.95%
2016-$2.202640%
2015-$0.08016-96.34%
2014-$2.19-2.53%
2013-$2.24-9.09%
2012-$2.47-37.14%
2011-$3.930%
2010-$3.93-39.66%
2009-$6.513.57%
2008-$6.28-8.2%
2007-$6.85-24.69%
2006-$9.0942.11%
2005-$6.40-22.97%
2004-$8.30-35.09%
2003-$12.79-0%
2002-$12.7962.86%
2001-$7.86-19.54%
2000-$9.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.04 729.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$59.90-5,594.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.42 1,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.25-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.59-2,355.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.52 314.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-$42.66 3,813.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.52-330.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.20 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA